New Drug ApprovalAbbisko’s PIMJETMI Wins FDA Approval After 56% Response in TGCT Abbisko’s PIMJETMI Wins FDA Approval After 56% Response in TGCT Read Post »
New Drug ApprovalBayer’s SUNHARBO Wins FDA Approval as First Factor XIa Inhibitor Bayer’s SUNHARBO Wins FDA Approval as First Factor XIa Inhibitor Read Post »
New Drug ApprovalPharming Gains MHRA Clearance for Paediatric Joenja Use in APDS Pharming Gains MHRA Clearance for Paediatric Joenja Use in APDS Read Post »
New Drug ApprovalJohnson & Johnson Wins FDA Approval for Rybrevant Faspro in HNSCC Johnson & Johnson Wins FDA Approval for Rybrevant Faspro in HNSCC Read Post »
New Drug ApprovalBayer Wins China Approval for Sevabertinib After 75% Response Rate Bayer Wins China Approval for Sevabertinib After 75% Response Rate Read Post »
New Drug ApprovalMHRA Conditionally Authorises Ultragenyx’s Dojolvi for LC-FAOD MHRA Conditionally Authorises Ultragenyx’s Dojolvi for LC-FAOD Read Post »
New Drug ApprovalINOVIO Wins FDA Approval for VOCERYQ to Reduce RRP Surgeries INOVIO Wins FDA Approval for VOCERYQ to Reduce RRP Surgeries Read Post »
New Drug ApprovalVertex Expands Casgevy Approval to Children Aged Five in the UK Vertex Expands Casgevy Approval to Children Aged Five in the UK Read Post »
New Drug ApprovalSun’s ILUMYA Gains New FDA Indication Following INSPIRE Trials Sun’s ILUMYA Gains New FDA Indication Following INSPIRE Trials Read Post »
New Drug ApprovalAstraZeneca’s Enhertu Wins EU Approval in Early Breast Cancer AstraZeneca’s Enhertu Wins EU Approval in Early Breast Cancer Read Post »
New Drug ApprovalFDA Approves Pfizer’s TALZENNA Plus XTANDI for HRR-Mutated mHSPC FDA Approves Pfizer’s TALZENNA Plus XTANDI for HRR-Mutated mHSPC Read Post »
New Drug ApprovalAstraZeneca Wins FDA Approval for Ultomiris in IgA Nephropathy AstraZeneca Wins FDA Approval for Ultomiris in IgA Nephropathy Read Post »
New Drug ApprovalMerck Wins EU Approval for KEYTRUDA Plus Padcev in Resectable MIBC Merck Wins EU Approval for KEYTRUDA Plus Padcev in Resectable MIBC Read Post »
New Drug ApprovalBioCryst Wins FDA Approval for ORLADEYO 150 mg Pellets in HAE BioCryst Wins FDA Approval for ORLADEYO 150 mg Pellets in HAE Read Post »
New Drug ApprovalGSK Gains FDA Approval for Hibsago After Positive B-WELL Trials GSK Gains FDA Approval for Hibsago After Positive B-WELL Trials Read Post »
New Drug ApprovalFDA Approves EVOXAC Oral Solution for Sjögren’s Disease FDA Approves EVOXAC Oral Solution for Sjögren’s Disease Read Post »
New Drug ApprovalJemperli Wins FDA Approval for MSI-H/dMMR Rectal Cancer Jemperli Wins FDA Approval for MSI-H/dMMR Rectal Cancer Read Post »
New Drug ApprovalViatris Wins FDA Approval for RYZUMVI to Treat Presbyopia in Adults Viatris Wins FDA Approval for RYZUMVI to Treat Presbyopia in Adults Read Post »
New Drug ApprovalUCB Wins FDA Approval for ZILBRYSQ Autoinjector With 99.8% Dose Delivery UCB Wins FDA Approval for ZILBRYSQ Autoinjector With 99.8% Dose Delivery Read Post »
New Drug ApprovalRoche Wins FDA Approval for Enspryng Despite Mixed Phase III Results Roche Wins FDA Approval for Enspryng Despite Mixed Phase III Results Read Post »
New Drug ApprovalFDA Expands ANKTIVA Approval to High-Grade Papillary-Only Bladder Cancer FDA Expands ANKTIVA Approval to High-Grade Papillary-Only Bladder Cancer Read Post »
New Drug ApprovalFDA Approves HOVILPRI for Refractory HSV Lesions in Immunocompromised Adult... FDA Approves HOVILPRI for Refractory HSV Lesions in Immunocompromised Adult... Read Post »
New Drug ApprovalFDA Approves Tecentriq Plus Chemotherapy for Stage III dMMR Colon Cancer FDA Approves Tecentriq Plus Chemotherapy for Stage III dMMR Colon Cancer Read Post »
New Drug ApprovalTeva Wins FDA Approval for WELTRUZA in Schizophrenia Teva Wins FDA Approval for WELTRUZA in Schizophrenia Read Post »
New Drug ApprovalFDA Approves Rhapsido as First Treatment for Symptomatic Dermographism FDA Approves Rhapsido as First Treatment for Symptomatic Dermographism Read Post »
New Drug ApprovalFDA Approves TUKYSA as First-Line Maintenance in Breast Cancer FDA Approves TUKYSA as First-Line Maintenance in Breast Cancer Read Post »
New Drug ApprovalJaypirca FDA Approval Expands Pirtobrutinib Use in CLL/SLL Jaypirca FDA Approval Expands Pirtobrutinib Use in CLL/SLL Read Post »
New Drug ApprovalFDA Approves Gazyva (Obinutuzumab) for Idiopathic Nephrotic Syndrome in Pat... FDA Approves Gazyva (Obinutuzumab) for Idiopathic Nephrotic Syndrome in Pat... Read Post »
New Drug ApprovalFDA Approves EMCITATE® (tiratricol), First Treatment for MCT8 Deficiency FDA Approves EMCITATE® (tiratricol), First Treatment for MCT8 Deficiency Read Post »
New Drug ApprovalFDA Approves WELIREG Plus LENVIMA for Advanced ccRCC FDA Approves WELIREG Plus LENVIMA for Advanced ccRCC Read Post »
New Drug ApprovalAbbVie’s Jumvo (Tavapadon) Receives FDA Approval for Parkinson’s Diseas... AbbVie’s Jumvo (Tavapadon) Receives FDA Approval for Parkinson’s Diseas... Read Post »
New Drug ApprovalFDA Approves Atebrioz (zilurgisertib) for FOP Treatment FDA Approves Atebrioz (zilurgisertib) for FOP Treatment Read Post »
New Drug ApprovalFDA Expands Olumiant Approval to Adolescents with Severe Alopecia Areata FDA Expands Olumiant Approval to Adolescents with Severe Alopecia Areata Read Post »
New Drug ApprovalFDA Approves Belzutifan Plus Lenvatinib for Advanced RCC With a Clear Cell ... FDA Approves Belzutifan Plus Lenvatinib for Advanced RCC With a Clear Cell ... Read Post »
New Drug ApprovalLilly Wins FDA Approval for Once-Weekly Basal Insulin Onswik in Type 2 Diab... Lilly Wins FDA Approval for Once-Weekly Basal Insulin Onswik in Type 2 Diab... Read Post »
New Drug ApprovalFDA Approves Lyrfigtu for FGFR2-Positive Cholangiocarcinoma FDA Approves Lyrfigtu for FGFR2-Positive Cholangiocarcinoma Read Post »
New Drug ApprovalRINVOQ Gains EU Approval for Pediatric Polyarticular JIA RINVOQ Gains EU Approval for Pediatric Polyarticular JIA Read Post »
New Drug ApprovalRoche Susvimo Wins EU Approval for Neovascular AMD Roche Susvimo Wins EU Approval for Neovascular AMD Read Post »
New Drug ApprovalFDA Grants Full Approval to Inluriyo Plus Verzenio for ESR1-Mutated Advance... FDA Grants Full Approval to Inluriyo Plus Verzenio for ESR1-Mutated Advance... Read Post »
New Drug ApprovalFDA Approves Aqneursa for Ataxia in Patients with Ataxia-Telangiectasia FDA Approves Aqneursa for Ataxia in Patients with Ataxia-Telangiectasia Read Post »
New Drug ApprovalSogroya Gets Positive EU Opinion for Idiopathic Short Stature Sogroya Gets Positive EU Opinion for Idiopathic Short Stature Read Post »
New Drug ApprovalFDA Approves FAYUVI for Sanfilippo Syndrome Type A FDA Approves FAYUVI for Sanfilippo Syndrome Type A Read Post »
New Drug ApprovalFDA Approves Kerendia for Type 1 Diabetes-Associated CKD FDA Approves Kerendia for Type 1 Diabetes-Associated CKD Read Post »
New Drug ApprovalFDA Approves Curium’s BEXLUTRY as First Radioligand Equivalent to LUTATHE... FDA Approves Curium’s BEXLUTRY as First Radioligand Equivalent to LUTATHE... Read Post »
New Drug ApprovalFDA Approves Ameluz PDT for Superficial Basal Cell Carcinoma FDA Approves Ameluz PDT for Superficial Basal Cell Carcinoma Read Post »
New Drug ApprovalFDA Approves Pixclara as First FET-PET Imaging Drug for Glioma FDA Approves Pixclara as First FET-PET Imaging Drug for Glioma Read Post »
New Drug ApprovalPharming Wins FDA Approval to Expand Joenja to Children With APDS Pharming Wins FDA Approval to Expand Joenja to Children With APDS Read Post »
New Drug ApprovalFDA Approves ISEMBYLD as First Muscle-Targeted Therapy for Spinal Muscular ... FDA Approves ISEMBYLD as First Muscle-Targeted Therapy for Spinal Muscular ... Read Post »
Disease & Drugs New Drug ApprovalFDA Expands Sevabertinib Approval to First-Line HER2-Mutant NSCLC FDA Expands Sevabertinib Approval to First-Line HER2-Mutant NSCLC Read Post »
New Drug ApprovalAstraZeneca Camizestrant Wins FDA Approval in ESR1 Breast Cancer AstraZeneca Camizestrant Wins FDA Approval in ESR1 Breast Cancer Read Post »